Shreeoswal Seeds & Chemicals
- P/E
- 8.38
Key Fundamentals
MicrocapConsumer GoodsFMCGPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 14.40%
- Debt to Equity
- 1.22
- EPS (TTM)
- ₹1.33
- Book Value
- ₹5.58
- Market Cap
- —
- P/E (TTM)
- 8.38
- P/B
- 2.00
- ROE
- 15.40%
- Dividend Yield
- 0.00%
- EBITDA
- ₹14.90 Cr
- 52W High
- ₹20.28
- 52W Low
- ₹9.66
- Day Range
- ₹10.82 – ₹11.78
- Volume
- 1,01,713
Peer Comparison
Fast Moving Consumer Goods › FMCG › Agricultural Products › Other Agricultural Products
| ₹410.10 | 22.24 | ₹14,281 Cr | 2.91 | 0.73% | 14.70% | 17.60% | ₹11,633 Cr | ₹640 Cr | |
| ₹408.65 | 12.33 | ₹9,318 Cr | 1.50 | 1.12% | 11.70% | 15.20% | ₹6,009 Cr | ₹758 Cr | |
| ₹152.09 | 16.77 | ₹6,847 Cr | 1.94 | 0.20% | 9.72% | 12.50% | ₹6,032 Cr | ₹416 Cr | |
| ₹680.25 | 14.02 | ₹3,469 Cr | 1.73 | 0.75% | 15.00% | 15.80% | ₹1,279 Cr | ₹249 Cr | |
| ₹369.45 | 20.27 | ₹3,167 Cr | 1.96 | 0.00% | 8.38% | 10.40% | ₹2,050 Cr | ₹159 Cr | |
| ₹222.57 | 15.79 | ₹2,241 Cr | 2.33 | 0.00% | 15.80% | 15.70% | ₹2,627 Cr | ₹132 Cr | |
| ₹92.98 | 23.84 | ₹1,926 Cr | 3.21 | 0.48% | 14.20% | 14.00% | ₹1,869 Cr | ₹77 Cr | |
| Shreeoswal Seeds & Chemicals (this company) | ₹11.14 | 8.38 | ₹101 Cr | 2.00 | 0.00% | 15.40% | 14.40% | ₹267 Cr | ₹12 Cr |
| Median 8 companies | ₹296.01 | 16.28 | ₹3,318 Cr | 1.98 | 0.34% | 14.45% | 14.80% | ₹2,338 Cr | ₹204 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 46
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 52
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 37
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 45
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 43
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 63
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
6- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 9.02% over past five years.
- Company has a low return on equity of 5.05% over last 3 years.
- Contingent liabilities of Rs.226 Cr.
- Debtor days have increased from 31.1 to 50.9 days.
- Promoter holding has decreased over last 3 years: -3.35%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 6 | 4 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 41.53
- Neutral
- MACD (12,26,9)
- −0.39
- Bullish
- SMA (50)
- 12.27
- Bearish
- SMA (200)
- 12.01
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +9.02% |
|---|---|
| 3Y | −3.03% |
| 1Y | +0.81% |
| TTM | 0.00% |
Net profit
| 5Y | +11.84% |
|---|---|
| 3Y | +5.27% |
| 1Y | +75.00% |
| TTM | −7.69% |
Operating cash flow
| 5Y | Outflow widened by ₹3 Cr |
|---|---|
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +1.08 pp |
|---|---|
| 3Y | +1.64 pp |
| 1Y | +1.98 pp |
| TTM | −0.74 pp |
Revenue by year
| Mar 2018 | ₹18.00 Cr |
|---|---|
| Mar 2019 | ₹126 Cr |
| Mar 2020 | ₹117 Cr |
| Mar 2021 | ₹161 Cr |
| Mar 2022 | ₹241 Cr |
| Mar 2023 | ₹272 Cr |
| Mar 2024 | ₹269 Cr |
| Mar 2025 | ₹246 Cr |
| Mar 2026 | ₹248 Cr |
Net profit by year
| Mar 2018 | ₹1.00 Cr |
|---|---|
| Mar 2019 | ₹3.00 Cr |
| Mar 2020 | ₹3.00 Cr |
| Mar 2021 | ₹4.00 Cr |
| Mar 2022 | ₹5.00 Cr |
| Mar 2023 | ₹6.00 Cr |
| Mar 2024 | −₹4.00 Cr |
| Mar 2025 | ₹4.00 Cr |
| Mar 2026 | ₹7.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 83 | 66 | 77 | 43 | 77 | 68 | 75 | 26 | 98 | 39 | 55 | 56 | 117 |
| Expenses | 79 | 63 | 78 | 48 | 79 | 66 | 67 | 24 | 87 | 43 | 52 | 52 | 99 |
| Operating Profit | 4 | 2 | −1 | −5 | −2 | 2 | 8 | 2 | 11 | −4 | 3 | 4 | 18 |
| OPM % | 5% | 3.7% | −1.5% | −11% | −2.6% | 2.3% | 11% | 8% | 11% | −9% | 5% | 7% | 16% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 3 | 1 | −3 | −6 | −4 | 0.46 | 7 | 1 | 10 | −5 | 1 | 3 | 17 |
| Tax % | 28% | 28% | 15% | −43% | −24% | 31% | 26% | 40% | 28% | −31% | 28% | 22% | 27% |
| Net Profit | 2 | 1 | −3 | −4 | −3 | 0 | 5 | 1 | 7 | −3 | 1 | 2 | 12 |
| EPS (₹) | 0.22 | 0.07 | −0.36 | −0.38 | −0.3 | 0.03 | 0.59 | 0.06 | 0.8 | −0.35 | 0.11 | 0.23 | 1.34 |
Profit & Loss
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18 | 126 | 117 | 161 | 241 | 272 | 269 | 246 | 248 | 267 |
| Expenses | 16 | 120 | 110 | 154 | 230 | 260 | 268 | 236 | 234 | 246 |
| Operating Profit | 2 | 6 | 7 | 8 | 10 | 12 | 1 | 10 | 15 | 22 |
| OPM % | 10% | 5% | 6% | 4.8% | 4.3% | 4.4% | 0.4% | 3.9% | 6% | 8% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 2 | 2 | 2 | 3 | 4 | 6 | 4 | 5 | 5 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| PBT | 1 | 4 | 4 | 5 | 8 | 8 | −5 | 5 | 10 | 16 |
| Tax % | 20% | 26% | 28% | 28% | 28% | 28% | −23% | 31% | 25% | — |
| Net Profit | 1 | 3 | 3 | 4 | 5 | 6 | −4 | 4 | 7 | 12 |
| EPS (₹) | 0.18 | 0.31 | 0.33 | 0.4 | 0.59 | 0.62 | −0.45 | 0.39 | 0.79 | 1.33 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 15 | 15 | 15 | 15 | 15 | 18 | 18 | 18 |
| Reserves | 1 | 11 | 14 | 18 | 23 | 29 | 22 | 25 | 33 |
| Borrowings | 25 | 24 | 30 | 43 | 42 | 41 | 64 | 42 | 62 |
| Other Liabilities | 15 | 11 | 7 | 16 | 40 | 43 | 20 | 19 | 28 |
| Total Liabilities | 52 | 61 | 66 | 93 | 120 | 128 | 124 | 105 | 141 |
| Fixed Assets | 2 | 2 | 4 | 4 | 4 | 4 | 7 | 6 | 8 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 50 | 59 | 63 | 89 | 115 | 122 | 115 | 96 | 131 |
| Total Assets | 52 | 61 | 66 | 93 | 120 | 128 | 124 | 105 | 141 |
Cash Flow
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | −10 | −10 | −4 | −11 | 5 | 12 | −15 | 24 | −14 |
| Investing | 0 | 1 | −3 | 0 | −1 | −2 | −4 | −1 | −1 |
| Financing | 10 | 13 | 4 | 10 | −4 | −6 | 17 | −26 | 15 |
| Net Cash Flow | 0 | 3 | −3 | −1 | 1 | 3 | −2 | −3 | 1 |
| Free Cash Flow | −10 | −10 | −6 | −12 | 4 | 11 | −19 | 24 | −14 |
| CFO/EBITDA | −525 | −149 | −38 | −123 | 72 | 119 | −1,388 | 253 | −87 |
Ratios
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 227 | 32 | 39 | 14 | 29 | 11 | 24 | 19 | 51 |
| Inventory Days | 790 | 134 | 147 | 190 | 144 | 147 | 1,540 | 474 | — |
| Days Payable | 334 | 28 | 3 | 4 | 5 | 4 | 53 | 30 | — |
| Cash Conversion Cycle | 683 | 137 | 182 | 201 | 168 | 154 | 1,511 | 462 | 51 |
| Working Capital Days | 211 | 59 | 74 | 75 | 56 | 47 | 36 | 49 | 61 |
| ROCE % | — | 14% | 12% | 11% | 13% | 14% | 1% | 10% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Shreeoswal Seeds & Chemicals insights
59 extracted metrics across FY18–FY27.
Documents
- 13 Aug 2026
- 30 May 2026
- 12 Feb 2026
- 14 Nov 2025
- Certificate under sebi (depositories and participa 13 Oct 2026
Frequently Asked Questions about Shreeoswal Seeds & Chemicals
What does Shreeoswal Seeds & Chemicals Ltd do?
Where is Shreeoswal Seeds & Chemicals Ltd (OSWALSEEDS) listed?
Which sector does Shreeoswal Seeds & Chemicals Ltd belong to?
What is the PE ratio of Shreeoswal Seeds & Chemicals Ltd?
What is the 52-week high and low of Shreeoswal Seeds & Chemicals Ltd?
What is the Return on Equity (ROE) of Shreeoswal Seeds & Chemicals Ltd?
Company Information
Incorporated in 2017, ShreeOswal Seeds and Chemicals Ltd is in the grain seed selling business
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/OSWALSEEDS.md for Shreeoswal Seeds & Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.